Loading stock data…
COO
$68.62+1.83 (+2.74%)
After Hours$68.26-0.36 (-0.52%)· Last close Jun 9
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
The Cooper Companies, Inc. in the Healthcare sector is trading at $68.62. Wall Street consensus targets $80.79 (14 analysts), implying a +17.7% move over the next 12 months. The stock is currently 24% below its 52-week high of $89.83, remaining 5.7% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: RSI 73 is overbought against a weak tape. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +17.7% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Overbought RSI 73 against a weak tape — risk of pullback
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Anchored to each ticker's own 5-year median trailing P/E, tilted by current ROE and growth. Fair P/E = own median P/E + (ROE × 10) + (max(revenue growth, earnings growth) × 15), capped at ±30% around the historical anchor. Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. Premium compounders like COST/MSFT are judged against their own multi-year norm rather than a sector median. Falls back to the sector-anchored formula (Tech ≈ 28, Comm Services ≈ 24, Utilities ≈ 18, Financials ≈ 14, etc.) for recent IPOs and tickers with insufficient history (< 24 monthly samples). Result is a normalised multiple gauge — not a price target.
Current Price$68.62
Potential Downside
0%
Whystock Fair Value$68.62
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus14 analysts
Buy
Mean target$80.79+17.7%
Range$66.00 – $95.00
Fundamentals
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifo...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
-
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
4.80%
Volume
Today's trading volume
4.31M
Recent News
The Cooper Companies (COO) Reliance on International Sales: What Investors Need to Know
Evaluate The Cooper Companies' (COO) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.
Stock Index Futures Climb as Tech Stocks Rebound, U.S. Inflation Data and SpaceX IPO Awaited
June S&P 500 E-Mini futures (ESM26) are up +0.71%, and June Nasdaq 100 E-Mini futures (NQM26) are up +1.40% this morning, signaling a rebound from Friday’s selloff on Wall Street as investors stepped in to buy the dip in technology stocks even as tensions in the Middle East pushed oil prices higher.
Company News for Jun 8, 2026
Companies In The News Are: GIII, ABM, TTAN, COO.
Cooper Companies (COO) Is Up 10.0% After Record Sales, Litigation Hit and Buyback Completion - What's Changed
Earlier this week, The Cooper Companies reported second-quarter 2026 results showing record sales of US$1,081.5 million but a net loss of US$77.9 million, largely due to a US$271.6 million litigation charge tied to a 2023 CooperSurgical product recall. The company paired this with updated full-year 2026 revenue guidance of about US$4.29–US$4.32 billion, confirmation of stronger non‑GAAP earnings, and completion of a long-running share repurchase program totaling over US$1.14 billion,...
US Equity Indexes Plummet as Dwindling Expectations for Monetary Policy Easing Decimate Mega-Cap Technology
US equity indexes plunged amid a slide in mega-cap chip names and government bonds, as a strong jobs